WILMINGTON – Incyte Corp. announced Monday that it has signed a collaboration and license agreement valued at up to $117.5 million with InnoCare, a Chinese biopharmaceutical company. The deal gives Beijing-based InnoCare the rights to ...
In this week’s edition, you will find a spotlight piece regarding new efforts to build out Delaware’s advanced laboratory space in order to prevent an exodus of incubated research firms from the First State. To ...